Dalbavancin is a long-acting lipoglycopeptide antibiotic used to treat bacterial infections. Dalbavancin impurities are substances that may be present in the drug product, which are not the active ingredient. These impurities can be formed during the manufacturing process or during storage. It is important to control impurities to ensure the quality, safety, and efficacy of the drug product. The identification and quantification of impurities are crucial steps in the drug development process. Regulatory
